GEN Exclusives

More »

Best of the Web

More »
May 15, 2010 (Vol. 30, No. 10)

Proteomics Tweets

URL:www.proteomics-tweets.com
  • Constantly updated, only includes tweets specific to proteomics
  • Includes many commercial tweets (including by the company that se up the website)

It was only a matter of time that in today’s climate of social media, websites would pop up to sort through the information with which we are constantly inundated. Proteomics Tweets may not be the first “twitter hub” website (and I’m certain it won’t be the last!), but it is the first scientifically oriented twitter hub that I have encountered. Now I don’t pretend to be all that Twitter savvy, but the idea behind Proteomics Tweets is to search all of the tweets worldwide for specific keywords related to proteomics, and to present those tweets on this site. Thus, to people interested in proteomics, this page acts as a filter for all of the twitter madness, and it is constantly updated. I do find that many of the tweets are commercial in nature, no doubt because companies are trying to cash in on the social media phenomenon. Still, it’s a nice way to view pertinent tidbits of information without having to join Twitter yourself.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?